Solas Capital Management, LLC
- SEC CIK
- 0001604867
- Latest filing
- Aug 14, 2026
FENC holding history
Fennec Pharmaceuticals Inc. in every 13F filed by Solas Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FENC overviewAll 13F holders of FENCFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,889,366
- Value
- $20.3M
- % of portfolio
- 10.9%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,889,366 | $20.3M | 10.9% | −592,832−23.9% | Reduced | Holders |
| Q1 2026 | 2,482,198 | $15.3M | 8.8% | −78,528−3.1% | Reduced | Holders |
| Q4 2025 | 2,560,726 | $19.7M | 11.2% | +372,824+17.0% | Added | Holders |
| Q3 2025 | 2,187,902 | $20.5M | 12.5% | −45,000−2.0% | Reduced | Holders |
| Q2 2025 | 2,232,902 | $18.5M | 10.4% | −18,017−0.8% | Reduced | Holders |
| Q1 2025 | 2,250,919 | $13.7M | 7.7% | 00.0% | Unchanged | Holders |
| Q4 2024 | 2,250,919 | $14.2M | 9.4% | +327,383+17.0% | Added | Holders |
| Q3 2024 | 1,923,536 | $9.62M | 6.8% | +583,536+43.5% | Added | Holders |
| Q2 2024 | 1,340,000 | $8.19M | 4.5% | +229,767+20.7% | Added | Holders |
| Q1 2024 | 1,110,233 | $12.3M | 7.9% | −268,280−19.5% | Reduced | Holders |
| Q4 2023 | 1,378,513 | $15.5M | 9.6% | −347,054−20.1% | Reduced | Holders |
| Q3 2023 | 1,725,567 | $13.0M | 9.1% | +286,539+19.9% | Added | Holders |
| Q2 2023 | 1,439,028 | $12.7M | 8.5% | +154,485+12.0% | Added | Holders |
| Q1 2023 | 1,284,543 | $10.7M | 5.7% | +32,155+2.6% | Added | Holders |
| Q4 2022 | 1,252,388 | $12.0M | 7.2% | +121,221+10.7% | Added | Holders |
| Q3 2022 | 1,131,167 | $9.16M | 5.6% | −42,349−3.6% | Reduced | Holders |
| Q2 2022 | 1,173,516 | $6.55M | 3.9% | +27,720+2.4% | Added | Holders |
| Q1 2022 | 1,145,796 | $6.42M | 3.9% | +277,939+32.0% | Added | Holders |
| Q4 2021 | 867,857 | $3.82M | 2.7% | 00.0% | Unchanged | Holders |
| Q3 2021 | 867,857 | $8.18M | 5.7% | 00.0% | Unchanged | Holders |
| Q2 2021 | 867,857 | $6.33M | 4.4% | +67,857+8.5% | Added | Holders |
| Q1 2021 | 800,000 | $4.97M | 4.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.